Education
About Us
Working with TipRanks
Follow Us
InhaleRx Limited (AU:IRX)
ASX:IRX
Total Valuation
InhaleRx Limited has a market cap or net worth of AU$5.67M. The enterprise value is AU$7.97M.
Market CapAU$5.67M
Enterprise ValueAU$7.97M
Share Statistics
InhaleRx Limited has 217,948,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding217,948,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
InhaleRx Limited’s return on equity (ROE) is 19.95 and return on invested capital (ROIC) is 3073.55%.
Return on Equity (ROE)19.95
Return on Assets (ROA)-1.79
Return on Invested Capital (ROIC)3073.55%
Return on Capital Employed (ROCE)20.85
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.47
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of InhaleRx Limited is ―. InhaleRx Limited’s PEG ratio is 0.28.
PE Ratio―
PS Ratio22.29
PB Ratio-116.78
Price to Fair Value-116.78
Price to FCF-20.26
Price to Operating Cash Flow-21.82
PEG Ratio0.28
Income Statement
In the last 12 months, InhaleRx Limited had revenue of 335.10K and earned -1.28M in profits. Earnings per share was -0.01.
Revenue335.10K
Gross Profit335.10K
Operating Income-1.33M
Pretax Income-1.28M
Net Income-1.28M
EBITDA0.00
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -293.46K and capital expenditures 0.00, giving a free cash flow of -293.46K billion.
Operating Cash Flow-293.46K
Free Cash Flow-293.46K
Free Cash Flow per Share>-0.01
Dividends & Yields
InhaleRx Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change0.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)48.02
Average Volume (3m)66.75K
Important Dates
InhaleRx Limited upcoming earnings date is Feb 23, 2026, TBA (Confirmed).
Last Earnings DateAug 24, 2025
Next Earnings DateFeb 23, 2026
Ex-Dividend Date―
Financial Position
InhaleRx Limited as a current ratio of 0.92, with Debt / Equity ratio of -38.34%
Current Ratio0.92
Quick Ratio0.92
Debt to Market Cap<0.01
Net Debt to EBITDA0.00
Interest Coverage Ratio-15.09
Taxes
In the past 12 months, InhaleRx Limited has paid -401.81K in taxes.
Income Tax-401.81K
Effective Tax Rate0.31
Enterprise Valuation
InhaleRx Limited EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -19.82.
EV to Sales21.81
EV to EBITDA0.00
EV to Free Cash Flow-19.82
EV to Operating Cash Flow-19.82
Balance Sheet
InhaleRx Limited has AU$481.32K in cash and marketable securities with AU$336.25K in debt, giving a net cash position of AU$145.07K billion.
Cash & Marketable SecuritiesAU$481.32K
Total DebtAU$336.25K
Net CashAU$145.07K
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share>-AU$0.01
Margins
Gross margin is 100.00%, with operating margin of -396.04%, and net profit margin of -380.81%.
Gross Margin100.00%
Operating Margin-396.04%
Pretax Margin-380.81%
Net Profit Margin-380.81%
EBITDA Margin0.00%
EBIT Margin-401.68%
Analyst Forecast
The average price target for InhaleRx Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-55.00%